The clinical impact of pseudomonas aeruginosa eradication in bronchiectasis in a Dutch center of expertise

Author(s):  
Menno M. van der Eerden ◽  
A.L.P. Pieters ◽  
Marleen Bakker ◽  
R.A.S. Hoek ◽  
Josje Altenburg ◽  
...  
2011 ◽  
Vol 17 (3) ◽  
pp. 382-385 ◽  
Author(s):  
A.M.M. de Vrankrijker ◽  
R.W. Brimicombe ◽  
T.F.W. Wolfs ◽  
H.G.M. Heijerman ◽  
R. van Mansfeld ◽  
...  

2017 ◽  
Vol 131 ◽  
pp. 241-246 ◽  
Author(s):  
Malena Cohen-Cymberknoh ◽  
Nir Weigert ◽  
Alex Gileles-Hillel ◽  
Oded Breuer ◽  
Natalia Simanovsky ◽  
...  

2013 ◽  
Vol 39 (4) ◽  
pp. 495-512 ◽  
Author(s):  
Luiz Vicente Ribeiro Ferreira da Silva Filho ◽  
Flavia de Aguiar Ferreira ◽  
Francisco Jose Caldeira Reis ◽  
Murilo Carlos Amorim de Britto ◽  
Carlos Emilio Levy ◽  
...  

Evidence-based techniques have been increasingly used in the creation of clinical guidelines and the development of recommendations for medical practice. The use of levels of evidence allows the reader to identify the quality of scientific information that supports the recommendations made by experts. The objective of this review was to address current concepts related to the clinical impact, diagnosis, and treatment of Pseudomonas aeruginosa infections in patients with cystic fibrosis. For the preparation of this review, the authors defined a group of questions that would be answered in accordance with the principles of PICO–an acronym based on questions regarding the Patients of interest, Intervention being studied, Comparison of the intervention, and Outcome of interest. For each question, a structured review of the literature was performed using the Medline database in order to identify the studies with the methodological design most appropriate to answering the question. The questions were designed so that each of the authors could write a response. A first draft was prepared and discussed by the group. Recommendations were then made on the basis of the level of scientific evidence, in accordance with the classification system devised by the Oxford Centre for Evidence-Based Medicine, as well as the level of agreement among the members of the group.


2009 ◽  
Vol 58 (4) ◽  
pp. 285-290 ◽  
Author(s):  
Cristina Suárez ◽  
Carmen Peña ◽  
Fe Tubau ◽  
Laura Gavaldà ◽  
Adriana Manzur ◽  
...  

2009 ◽  
Vol 22 (4) ◽  
pp. 582-610 ◽  
Author(s):  
Philip D. Lister ◽  
Daniel J. Wolter ◽  
Nancy D. Hanson

SUMMARY Treatment of infectious diseases becomes more challenging with each passing year. This is especially true for infections caused by the opportunistic pathogen Pseudomonas aeruginosa, with its ability to rapidly develop resistance to multiple classes of antibiotics. Although the import of resistance mechanisms on mobile genetic elements is always a concern, the most difficult challenge we face with P. aeruginosa is its ability to rapidly develop resistance during the course of treating an infection. The chromosomally encoded AmpC cephalosporinase, the outer membrane porin OprD, and the multidrug efflux pumps are particularly relevant to this therapeutic challenge. The discussion presented in this review highlights the clinical significance of these chromosomally encoded resistance mechanisms, as well as the complex mechanisms/pathways by which P. aeruginosa regulates their expression. Although a great deal of knowledge has been gained toward understanding the regulation of AmpC, OprD, and efflux pumps in P. aeruginosa, it is clear that we have much to learn about how this resourceful pathogen coregulates different resistance mechanisms to overcome the antibacterial challenges it faces.


Sign in / Sign up

Export Citation Format

Share Document